AbbVie Inc. is 859.3x more valuable than Evotec SE by market capitalization ($399.47 B vs $464.89 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EVO | ABBV |
|---|---|---|
| Market cap | $464.89 M | $399.47 B |
| US-listed rank | #2673 | #28 |
| Revenue (latest FY) | - | $61.16B |
| Net income (latest FY) | - | $4.23B |
| Net margin | - | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 180 | 1,008 |
AbbVie Inc. is 859.3x more valuable than Evotec SE by market capitalization ($399.47 B vs $464.89 M).
Full pages: Evotec SE and AbbVie Inc., or browse the full rankings.